Swiss Biotech Launches Amidst Hot Streak for Rare Autoimmune Disease
Swiss biotech Chord Therapeutics launched this week with a €13.7M Series A, becoming the latest…
Swiss biotech Chord Therapeutics launched this week with a €13.7M Series A, becoming the latest…
The last month has seen several big investments in European neuromodulation and neurostimulation companies, which…
Novartis’ Kymriah, one of the first CAR T-cell therapies to be approved to treat blood…
Norway has not typically been an attractive region for biotech investors, so when Masha Strømme…
While there is no doubt that Europe has a thriving biotech scene, it can really…
It can pay to take your time and keep your options open when choosing a…
A request for market approval of a skin patch developed by French biotech DBV Technologies…
Italian biotech Enthera raised €28M in Series A funding to develop its drug candidate for…
The National Cyber Security Centre (NCSC) in the UK stated this week that several organizations…
Reapplix, a Danish biotech focusing on developing wound healing technology, has raised €19.8M in equity…
While there are now more cell therapies on offer than ever before, there are obstacles…
Researchers in the UK have set up a drug testing platform to bridge the gap…